Finance
Beau Wrigley making a huge bet on medical marijuana
-
William Wrigley Jr. II led a $65 million round into
Surterra, a Florida medical marijuana
company, through his private investment firm. - He’s also taking a seat on Surterra’s board.
-
Wrigley formerly ran the eponymous chewing gum company,
orchestrating its sale to Mars Inc.
William Wrigley Jr. II, the heir to the Wrigley chewing gum
fortune, is jumping into the marijuana business.
Wrigley led a $65 million equity financing into Surterra Wellness,
a Florida-based medical marijuana company, through
his personal investment firm.
Wrigley will also become the chair of Surterra’s board. The
company plans to use the funds to expand into new state markets —
and make a push into the competitive recreational market.
Known as Beau, Wrigley left the eponymous chewing gum
company after orchestrating the company’s sale to Mars
Inc.
“When I understood the massive benefits, it really changed
my mind about the [marijuana] industry,” Wrigley told
Bloomberg in a Monday interview. “You don’t see too many
opportunities to have that kind of an impact in an industry that
is being created from scratch.”
Recreational marijuana is legal
in nine states, and medical marijuana is legal in another 30,
though the federal government still considers it to be an
illegal, Schedule I substance. Oklahoma voted to
allow medicinal marijuana in June.
-
Entertainment7 days ago
WordPress.org’s login page demands you pledge loyalty to pineapple pizza
-
Entertainment6 days ago
‘Mufasa: The Lion King’ review: Can Barry Jenkins break the Disney machine?
-
Entertainment5 days ago
OpenAI’s plan to make ChatGPT the ‘everything app’ has never been more clear
-
Entertainment4 days ago
‘The Last Showgirl’ review: Pamela Anderson leads a shattering ensemble as an aging burlesque entertainer
-
Entertainment5 days ago
How to watch NFL Christmas Gameday and Beyoncé halftime
-
Entertainment4 days ago
Polyamorous influencer breakups: What happens when hypervisible relationships end
-
Entertainment3 days ago
‘The Room Next Door’ review: Tilda Swinton and Julianne Moore are magnificent
-
Entertainment3 days ago
CES 2025 preview: What to expect